• Wesfarmers and joint venture partner Sociedad Química y Minera de Chile (SQM) have approved a major expansion of the Mt Holland lithium project in Western Australia, aiming to double spodumene concentrate production by adding a second concentrator and an integrated ore sorting facility, with construction scheduled to begin in the second half of 2027 and expanded output targeted for the first half of 2030.
• A distinctive aspect of this decision is the focus on lower unit operating costs and improved recovery of stockpiled material, which could enhance the long-term efficiency and economics of SQM’s Australian lithium operations.
• We’ll now examine how doubling Mt Holland’s spodumene capacity and improving cost efficiency could influence SQM’s broader investment narrative and risk profile.

AI is about to change healthcare. These 39 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

Sociedad Química y Minera de Chile Investment Narrative Recap

To own SQM, you need to believe that lithium demand and pricing stay healthy enough for the company’s global growth projects to earn solid returns, while its iodine and specialty nutrients businesses support earnings through cycles. The Mt Holland expansion fits this story by adding long-dated, lower cost Australian supply, but its impact on SQM’s key short term swing factor lithium price volatility and on execution and CapEx risk is meaningful rather than transformational.

In that context, SQM’s strong Q1 2026 results, with sales of US$1,760.11 million and net income of US$364.72 million, show how sensitive earnings are to lithium and iodine conditions. Pairing that earnings power with the planned Mt Holland capacity uplift links today’s profitability with SQM’s longer term growth pipeline and highlights why both pricing risk and project execution risk remain central to the story.

Yet behind the growth projects, investors should be aware that concentrated exposure to long term lithium price swings and technological change could...

Sociedad Química y Minera de Chile's narrative projects $6.5 billion revenue and $1.9 billion earnings by 2028.

Uncover how Sociedad Química y Minera de Chile's forecasts yield a $75.33 fair value, a 9% upside to its current price.

Exploring Other Perspectives

Some of the lowest estimate analysts take a much harsher view than consensus, even before this Mt Holland news, assuming 2029 earnings of about US$1.6 billion and revenue near US$7.4 billion, and tying that to a lower 12x PE and faster global supply growth that could pressure prices far more than the baseline narrative suggests.

Explore 5 other fair value estimates on Sociedad Química y Minera de Chile - why the stock might be worth as much as 59% more than the current price!

Decide For Yourself

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Sociedad Química y Minera de Chile research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Sociedad Química y Minera de Chile research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Sociedad Química y Minera de Chile's overall financial health at a glance.

Interested In Other Possibilities?

Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:

• Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 29 best rare earth metal stocks of the very few that mine this essential strategic resource.
• Invest in the nuclear renaissance through our list of 90 elite nuclear energy infrastructure plays powering the global AI revolution.
• Uncover the next big thing with 21 elite penny stocks that balance risk and reward.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.